Papers associated with kcnc3

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes., Li X, Zheng Y, Li S, Nair U, Sun C, Zhao C, Lu J, Zhang VW, Maljevic S, Petrou S, Lin J., Ann Transl Med. September 1, 2021; 9 (18): 1397.
	V374A KCND3 Pathogenic Variant Associated With Paroxysmal Ataxia Exacerbations., Paucar M, Ågren R, Li T, Lissmats S, Bergendal Å, Weinberg J, Nilsson D, Savichetva I, Sahlholm K, Nilsson J, Svenningsson P., Neurol Genet. January 6, 2021; 7 (1): e546.
	A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy., Muona M, Berkovic SF, Dibbens LM, Oliver KL, Maljevic S, Bayly MA, Joensuu T, Canafoglia L, Franceschetti S, Michelucci R, Markkinen S, Heron SE, Hildebrand MS, Andermann E, Andermann F, Gambardella A, Tinuper P, Licchetta L, Scheffer IE, Criscuolo C, Filla A, Ferlazzo E, Ahmad J, Ahmad A, Baykan B, Said E, Topcu M, Riguzzi P, King MD, Ozkara C, Andrade DM, Engelsen BA, Crespel A, Lindenau M, Lohmann E, Saletti V, Massano J, Privitera M, Espay AJ, Kauffmann B, Duchowny M, Møller RS, Straussberg R, Afawi Z, Ben-Zeev B, Samocha KE, Daly MJ, Petrou S, Lerche H, Palotie A, Lehesjoki AE., Nat Genet. January 1, 2015; 47 (1): 39-46.
	Inhibition of human Kv3.1 current expressed in Xenopus oocytes by the toxic venom fraction of Androctonus australis hector., Cheikh A, Benkhalifa R, Landoulsi Z, Chatti I, Ayeb ME., Arch Pharm Res. November 1, 2014; 37 (11): 1445-53.
	Erratum to: Inhibition of human Kv3.1 current expressed in Xenopus oocytes by the toxic venom fraction of Androctonus australis hector., Cheikh A, Benkhalifa R, Landoulsi Z, Chatti I, El Ayeb M., Arch Pharm Res. November 1, 2014; 37 (11): 1505.
	Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells., Irie T, Matsuzaki Y, Sekino Y, Hirai H., J Physiol. January 1, 2014; 592 (1): 229-47.
	Analysis of the interaction of tarantula toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the voltage sensor of Kv2.1 uncovers the molecular basis for cross-activities on Kv2.1 and Nav1.5 channels., Tao H, Chen JJ, Xiao YC, Wu YY, Su HB, Li D, Wang HY, Deng MC, Wang MC, Liu ZH, Liang SP., Biochemistry. October 22, 2013; 52 (42): 7439-48.
	Spinocerebellar ataxia-13 Kv3.3 potassium channels: arginine-to-histidine mutations affect both functional and protein expression on the cell surface., Zhao J, Zhu J, Thornhill WB., Biochem J. September 1, 2013; 454 (2): 259-65.
	A novel mechanism for fine-tuning open-state stability in a voltage-gated potassium channel., Pless SA, Niciforovic AP, Galpin JD, Nunez JJ, Kurata HT, Ahern CA., Nat Commun. January 1, 2013; 4 1784.
	Intermediate state trapping of a voltage sensor., Lacroix JJ, Pless SA, Maragliano L, Campos FV, Galpin JD, Ahern CA, Roux B, Bezanilla F., J Gen Physiol. December 1, 2012; 140 (6): 635-52.
	Altered Kv3.3 channel gating in early-onset spinocerebellar ataxia type 13., Minassian NA, Lin MC, Papazian DM., J Physiol. April 1, 2012; 590 (7): 1599-614.
	Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia 13 (SCA13)., Figueroa KP, Waters MF, Garibyan V, Bird TD, Gomez CM, Ranum LP, Minassian NA, Papazian DM, Pulst SM., PLoS One. March 29, 2011; 6 (3): e17811.
	KCNC3: phenotype, mutations, channel biophysics-a study of 260 familial ataxia patients., Figueroa KP, Minassian NA, Stevanin G, Waters M, Garibyan V, Forlani S, Strzelczyk A, Bürk K, Brice A, Dürr A, Papazian DM, Pulst SM., Hum Mutat. February 1, 2010; 31 (2): 191-6.
	Dynamic coupling of voltage sensor and gate involved in closed-state inactivation of kv4.2 channels., Barghaan J, Bähring R., J Gen Physiol. February 1, 2009; 133 (2): 205-24.
	Protein kinase C modulates inactivation of Kv3.3 channels., Desai R, Kronengold J, Mei J, Forman SA, Kaczmarek LK., J Biol Chem. August 8, 2008; 283 (32): 22283-94.
	Sca13., Waters MF, Pulst SM., Cerebellum. January 1, 2008; 7 (2): 165-9.
	Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation., Decher N, Kumar P, Gonzalez T, Pirard B, Sanguinetti MC., Mol Pharmacol. October 1, 2006; 70 (4): 1204-11.
	Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current., Lagrutta A, Wang J, Fermini B, Salata JJ., J Pharmacol Exp Ther. June 1, 2006; 317 (3): 1054-63.
	Atypical phenotypes from flatworm Kv3 channels., Klassen TL, Buckingham SD, Atherton DM, Dacks JB, Gallin WJ, Spencer AN., J Neurophysiol. May 1, 2006; 95 (5): 3035-46.
	Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes., Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JP, Nolte D, Mock AF, Evidente VG, Fee DB, Müller U, Dürr A, Brice A, Papazian DM, Pulst SM., Nat Genet. April 1, 2006; 38 (4): 447-51.
	Pharmacology and surface electrostatics of the K channel outer pore vestibule., Quinn CC, Begenisich T., J Membr Biol. January 1, 2006; 212 (1): 51-60.
	A single residue in the S6 transmembrane domain governs the differential flecainide sensitivity of voltage-gated potassium channels., Herrera D, Mamarbachi A, Simoes M, Parent L, Sauvé R, Wang Z, Nattel S., Mol Pharmacol. August 1, 2005; 68 (2): 305-16.
	Deranged Kv channel regulation in fibroblasts from mice lacking the serum and glucocorticoid inducible kinase SGK1., Shumilina E, Lampert A, Lupescu A, Myssina S, Strutz-Seebohm N, Henke G, Grahammer F, Wulff P, Kuhl D, Lang F., J Cell Physiol. July 1, 2005; 204 (1): 87-98.
	U-type inactivation of Kv3.1 and Shaker potassium channels., Klemic KG, Kirsch GE, Jones SW., Biophys J. August 1, 2001; 81 (2): 814-26.
	Gallamine triethiodide selectively blocks voltage-gated potassium channels in Ranvier nodes., Hinck D, Wulff H, Koppenhöfer E., Gen Physiol Biophys. March 1, 2001; 20 (1): 83-95.
	Molecular evidence for a role of Shaw (Kv3) potassium channel subunits in potassium currents of dog atrium., Yue L, Wang Z, Rindt H, Nattel S., J Physiol. September 15, 2000; 527 Pt 3 467-78.
	Sensitivity of native and cloned hippocampal delayed-rectifier potassium channels to verapamil., Madeja M, Müller V, Musshoff U, Speckmann EJ., Neuropharmacology. January 4, 2000; 39 (2): 202-10.
	Regulation of Shaker-type potassium channels by hypoxia. Oxygen-sensitive K+ channels in PC12 cells., Conforti L, Millhorn DE., Adv Exp Med Biol. January 1, 2000; 475 265-74.
	Regulation of Ca2+-dependent K+ channel expression in rat cerebellum during postnatal development., Muller YL, Reitstetter R, Yool AJ., J Neurosci. January 1, 1998; 18 (1): 16-25.
	Role of transmembrane segment S5 on gating of voltage-dependent K+ channels., Shieh CC, Klemic KG, Kirsch GE., J Gen Physiol. June 1, 1997; 109 (6): 767-78.
	A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity., Cotton J, Crest M, Bouet F, Alessandri N, Gola M, Forest E, Karlsson E, Castañeda O, Harvey AL, Vita C, Ménez A., Eur J Biochem. February 15, 1997; 244 (1): 192-202.
	Hydrophobic mutations alter the movement of Mg2+ in the pore of voltage-gated potassium channels., Harris RE, Isacoff EY., Biophys J. July 1, 1996; 71 (1): 209-19.
	Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels., Jarolimek W, Soman KV, Alam M, Brown AM., Mol Pharmacol. January 1, 1996; 49 (1): 165-71.
	The P-region and S6 of Kv3.1 contribute to the formation of the ion conduction pathway., Aiyar J, Nguyen AN, Chandy KG, Grissmer S., Biophys J. December 1, 1994; 67 (6): 2261-4.
	Differential expression of Shaw-related K+ channels in the rat central nervous system., Weiser M, Vega-Saenz de Miera E, Kentros C, Moreno H, Franzen L, Hillman D, Baker H, Rudy B., J Neurosci. March 1, 1994; 14 (3 Pt 1): 949-72.
	Full-length and truncated Kv1.3 K+ channels are modulated by 5-HT1c receptor activation and independently by PKC., Aiyar J, Grissmer S, Chandy KG., Am J Physiol. December 1, 1993; 265 (6 Pt 1): C1571-8.
	Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels., Kirsch GE, Drewe JA., J Gen Physiol. November 1, 1993; 102 (5): 797-816.
	Stable expression and regulation of a rat brain K+ channel., Critz SD, Wible BA, Lopez HS, Brown AM., J Neurochem. March 1, 1993; 60 (3): 1175-8.
	The Shaw-related potassium channel gene, Kv3.1, on human chromosome 11, encodes the type l K+ channel in T cells., Grissmer S, Ghanshani S, Dethlefs B, McPherson JD, Wasmuth JJ, Gutman GA, Cahalan MD, Chandy KG., J Biol Chem. October 15, 1992; 267 (29): 20971-9.
	Modulation of K+ channels by hydrogen peroxide., Vega-Saenz de Miera E, Rudy B., Biochem Biophys Res Commun. August 14, 1992; 186 (3): 1681-7.
	Cloning of ShIII (Shaw-like) cDNAs encoding a novel high-voltage-activating, TEA-sensitive, type-A K+ channel., Vega-Saenz de Miera E, Moreno H, Fruhling D, Kentros C, Rudy B., Proc Biol Sci. April 22, 1992; 248 (1321): 9-18.

???pagination.result.page??? 1